SYNOTROL 400 TABLET

Product Description

SYNOTROL 400MG TABLET
(Sevelamer Carbonate Tablets 400 mg)

Product Description:

SYNOTROL 400MG TABLET is a premium-quality phosphate binder containing Sevelamer Carbonate 400 mg, specifically formulated to manage hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. This non-calcium, non-metal-based binder helps control elevated phosphate levels without increasing calcium load, reducing the risk of vascular calcification.

Manufactured under GMP-certified facilities, SYNOTROL 400MG is a reliable choice for hospitals, nephrology clinics, pharma wholesalers, and bulk medical suppliers seeking effective solutions for CKD patient care.

Key Benefits:

• Effectively lowers serum phosphate levels in CKD patients on dialysis

• Minimizes the risk of hypercalcemia and vascular calcification

• Suitable for both hemodialysis and peritoneal dialysis patients

• Proven gastrointestinal safety profile for long-term use

Usage/Application:
Recommended for adult patients undergoing dialysis treatment to control phosphate retention. Dosage should be as prescribed by a nephrologist or physician.

Why Choose SYNOTROL 400MG?

• Complies with international pharmacological standards

• Stable shelf life and high batch consistency

• Competitive pricing for bulk orders, tenders, and distributor supply chains

• Ideal for hospital procurement, B2B pharma exports, and nephrology product catalogs

Partner with us for trusted quality and assured supply of SYNOTROL 400MG your dependable solution for phosphate control in CKD patients